Loading clinical trials...

Visual and Electromyography Assessments in Response to Train-of-Four Stimulation of the Ulnar Nerve | Clinical Trials | Clareo Health

COMPLETEDNA

Visual and Electromyography Assessments in Response to Train-of-Four Stimulation of the Ulnar Nerve

Comparison of Visual and Electromyography Assessments in Response to Train-of-Four Stimulation of the Ulnar Nerve

NCT04352127•Mayo Clinic

View on ClinicalTrials.gov

Summary

Researchers are comparing the accuracy of measuring muscle relaxation during and after surgery with a device that provides numeric value versus visual observation to count of muscle twitches or absence of them by a medical provider monitoring your anesthesia during surgery.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Age \> or = 18 years old
•Patients willing to participate and provide an informed consent
•Patients undergoing an elective surgical procedure that requires use of NMBA agents administered intraoperatively.

Exclusion Criteria

•Patients with disorders, such as stroke, carpal tunnel syndrome, broken wrist with nerve damage, Dupuytren contracture, or any similar wrist injury.
•Patients with systemic neuromuscular diseases such as myasthenia gravis
•Patients with significant organ dysfunction that can significantly affect pharmacokinetics of neuromuscular blocking and reversal agents, i.e., severe renal impairment or end-stage liver disease.
•Patients having surgery that would involve prepping the arm or leg into the sterile field

Locations (1)

Mayo Clinic in Florida

Jacksonville, Florida, United States

Key Dates

Start Date

August 18, 2020

Primary Completion Date

June 29, 2021

Completion Date

June 29, 2021

Last Updated

November 10, 2022

Enrollment

ACTUAL participants

Conditions

Residual Neuromuscular Blockade

Interventions

TetraGraph

DEVICE

Incidence and Severity of Residual Neuromuscular Blockade

NCT02660398

Residual Neuromuscular Blockade

View study

COMPLETED

Predictor of Residual Neuromuscular Blockade in Recovery Room After General Anesthesia

NCT02146859

Residual Neuromuscular Blockade

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 10, 2022Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions